BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11208842)

  • 1. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.
    Packer RJ; Boyett JM; Janss AJ; Stavrou T; Kun L; Wisoff J; Russo C; Geyer R; Phillips P; Kieran M; Greenberg M; Goldman S; Hyder D; Heideman R; Jones-Wallace D; August GP; Smith SH; Moshang T
    J Clin Oncol; 2001 Jan; 19(2):480-7. PubMed ID: 11208842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.
    Olsson DS; Buchfelder M; Wiendieck K; Kremenevskaja N; Bengtsson BÅ; Jakobsson KE; Jarfelt M; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2012 Jun; 166(6):1061-8. PubMed ID: 22457235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of growth hormone replacement after CNS irradiation.
    Mackenzie S; Craven T; Gattamaneni HR; Swindell R; Shalet SM; Brabant G
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2756-61. PubMed ID: 21715535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: A Systematic Review and Cohort Study.
    van Schaik J; Kormelink E; Kabak E; van Dalen EC; Schouten-van Meeteren AYN; de Vos-Kerkhof E; Bakker B; Fiocco M; Hoving EW; Tissing WJE; van Santen HM
    Neuroendocrinology; 2023; 113(10):987-1007. PubMed ID: 37231961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency.
    Matsumoto R; Fukuoka H; Iguchi G; Nishizawa H; Bando H; Suda K; Takahashi M; Takahashi Y
    Growth Horm IGF Res; 2014 Oct; 24(5):174-9. PubMed ID: 25116471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
    Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic Growth Hormone-Replacement Therapy and Craniopharyngioma Recurrence in Pediatric Patients: A Meta-Analysis.
    Alotaibi NM; Noormohamed N; Cote DJ; Alharthi S; Doucette J; Zaidi HA; Mekary RA; Smith TR
    World Neurosurg; 2018 Jan; 109():487-496.e1. PubMed ID: 28987837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy and risk of recurrence/progression in intracranial tumors: a meta-analysis.
    Shen L; Sun CM; Li XT; Liu CJ; Zhou YX
    Neurol Sci; 2015 Oct; 36(10):1859-67. PubMed ID: 26048536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
    Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
    J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia.
    Leung W; Rose SR; Zhou Y; Hancock ML; Burstein S; Schriock EA; Lustig R; Danish RK; Evans WE; Hudson MM; Pui CH
    J Clin Oncol; 2002 Jul; 20(13):2959-64. PubMed ID: 12089225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height in children with medulloblastoma treated with growth hormone.
    Ranke MB; Price DA; Lindberg A; Wilton P; Darendeliler F; Reiter EO
    Horm Res; 2005; 64(1):28-34. PubMed ID: 16103682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
    Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
    Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.
    Walter AW; Mulhern RK; Gajjar A; Heideman RL; Reardon D; Sanford RA; Xiong X; Kun LE
    J Clin Oncol; 1999 Dec; 17(12):3720-8. PubMed ID: 10577843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
    Whitton AC; Syndikus I; Tait DM; Bloom HJ
    Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medulloblastoma: analysis of 14 cases treated at the J. Bordet Institute and literature review].
    Ismaili K; Sariban E; Otten J; Regnier R
    Rev Med Brux; 1992 Mar; 13(3):51-60. PubMed ID: 1561501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired longitudinal myocardial velocities in patients with growth hormone deficiency improves after hormone replacement therapy.
    Ozdogru I; Tanriverdi F; Dogan A; Kaya MG; Tugrul Inanc M; Kalay N; Topsakal R; Unluhizarci K; Atmaca H; Kemal Eryol N; Kelestimur F
    J Am Soc Echocardiogr; 2007 Sep; 20(9):1093-9. PubMed ID: 17555934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study.
    Luger A; Mattsson AF; Koltowska-Häggström M; Thunander M; Góth M; Verhelst J; Abs R
    Diabetes Care; 2012 Jan; 35(1):57-62. PubMed ID: 22074727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors.
    Bowers DC; Adhikari S; El-Khashab YM; Gargan L; Oeffinger KC
    Pediatr Blood Cancer; 2009 Dec; 53(7):1295-301. PubMed ID: 19688835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.